Therapeutic Drug Monitoring for Patients with HIV Infection
Steven J. Soldin, Natella Rakhmanina, Hans Spiegel, John L. Sever
Abstract
Steven J. Soldin, Natella Rakhmanina, Hans Spiegel, John L. Sever
Abstract
This paper provides a brief overview of therapeutic drug monitoring (TDM) in patients with HIV infection. The manuscipt not only focuses on an update on TDM in HIV infection but also provides the latest information on tandem mass spectrometric methods for antiretroviral drug quantification. Also discussed are the preliminary new and original data on free antiretroviral drug measurement in both plasma and saliva.
OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This paper provides a brief overview of therapeutic drug monitoring (TDM) in patients with HIV infection. The manuscipt not only focuses on an update on TDM in HIV infection but also provides the latest information on tandem mass spectrometric methods for antiretroviral drug quantification. Also discussed are the preliminary new and original data on free antiretroviral drug measurement in both plasma and saliva.
Key concepts: Therapeutic drug monitoring, Antiretroviral drug, Drug, Human immunodeficiency virus (HIV), Medicine, Antiretroviral therapy, Pharmacology, Virology